Filgotinib Maleate

DRUG2 trials

Sponsors

Eisai Korea Inc.

Conditions

Rheumatoid ArthritisUlcerative Colitis

Phase 4

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

CompletedNCT06625242

Eisai Korea Inc.Rheumatoid Arthritis

Start: 2024-10-22End: 2026-02-25Updated: 2026-05-11

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Active, not recruitingNCT06964113

Eisai Korea Inc.Ulcerative Colitis

Start: 2025-06-11End: 2027-11-30Target: 94Updated: 2026-07-02